Gilead, Johnson & Johnson file renewed motion to dismiss BCBS's US antitrust claims over HIV treatment
MLex Summary: Gilead and Johnson & Johnson filed a renewed motion to dismiss US antitrust claims filed by Blue Cross Blue Shield accusing them of conspiring to fix prices for combination...To view the full article, register now.
Already a subscriber? Click here to view full article